SCHEMBL8870965

SCHEMBL8870965

COc1cc2c(Nc3cccc(C)c3)ncnc2cc1OCCBr

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.81
FBP1 P09467 3/20 0.68
KDR P35968 7/20 0.65
SRC P12931 3/20 0.65
KDM4E B2RXH2 3/20 0.65
MAPT P10636 3/20 0.65
MAPK1 P28482 3/20 0.65
ERBB2 P04626 2/20 0.65
ABL1 P00519 2/20 0.65
CYP1A2 P05177 2/20 0.65
CYP3A4 P08684 2/20 0.65
CYP2D6 P10635 2/20 0.65
EPHB2 P29323 2/20 0.65
MAPK14 Q16539 2/20 0.65
MKNK1 Q9BUB5 2/20 0.65
GAK O14976 1/20 0.65
MAPK13 O15264 1/20 0.65
CDK1 P06493 1/20 0.65
CYP2C9 P11712 1/20 0.65
TSHR P16473 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2099775 0.90 EGFR (0.83) EGFRFBP1KDRSRCKDM4E
SCHEMBL5482883 0.90 EGFR (1.00) EGFRFBP1KDRSRCKDM4E
SCHEMBL31060707 0.90 EGFR (1.00) EGFRFBP1KDRSRCKDM4E
SCHEMBL2101009 0.89 EGFR (0.81) EGFRFBP1KDRSRCKDM4E
SCHEMBL4232360 0.89 FBP1 (0.84) EGFRFBP1KDRSRCKDM4E
Hydrochloric Acid SCHEMBL5478587 0.89 EGFR (0.97) EGFRFBP1KDRSRCKDM4E
SCHEMBL8871648 0.88 EGFR (0.78) EGFRFBP1KDRSRCKDM4E
SCHEMBL799667 0.87 EGFR (0.78) EGFRFBP1KDRSRCERBB2
SCHEMBL8870952 0.87 EGFR (0.76) EGFRFBP1KDRSRCKDM4E
SCHEMBL19885292 0.86 EGFR (0.74) EGFRFBP1KDRSRCKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616582-A Use as anticancer agents; e.g. gefitinib ZENECA LIMITED (GB) 1997-04-01 US disclosed
EP-0566226-B1 Quinazoline derivatives ZENECA LTD (GB) 1995-11-08 EP disclosed
US-5457105-A anticancer use; e.g. 4-(3'-chloro-4'-fluoroanilino)-6,7-dimethoxyquinazoline (gefitinib) ZENECA LIMITED (GB) 1995-10-10 US disclosed
EP-0566226-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1993-10-20 EP disclosed